Key Medicine Shortages - October 2020
Monthly Update
1. Enalapril – 20mg tablets are currently unavailable. Other strengths of enalapril tablets are currently available, so it is unlikely the unlicensed 20mg tablets will be required. A short supply issue may arise due to increased demand for lower strengths of enalapril. For further advice please refer to NHSGGC Memo (on StaffNet) and Medicine Supply Alert Notice.
2. Zonisamide – 50mg and 100mg capsules are unavailable from manufacturer, Teva. All strengths of capsules remain available from other manufacturers. If switching between different manufacturers, patients should be advised to report any changes in seizure frequency to their GP.
For further advice please refer to Medicine Supply Alert Notice.
Why do medicine shortages occur?
Medicine shortages occur for a variety of reasons, including difficulties sourcing raw materials, product recalls for safety reasons, changes to licence holder, and changes to pack sizes.
It is vitally important that medicine shortages are monitored and appropriate actions taken, to minimise impact on patient care.
Where can I find further advice and information on medicine supply problems and shortages?
For the most up-to-date advice and information please refer to Current Medicine Supply Problems and Shortages page on StaffNet.
Published 03/11/2020. Medicines Update blogs are correct at the time of publication.